[
  {
    "ts": "2026-01-12T01:31:34+00:00",
    "headline": "Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight",
    "summary": "On Thursday, Eli Lilly and Co. (NYSE:LLY) revealed topline results from the novel TOGETHER-PsA open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone for active psoriatic arthritis (PsA) and obesity or overweight with at least one weight-related condition. Psoriatic arthritis is linked to psoriasis (a condition that affects skin and nails). It causes joint pain, stiffness, and a skin rash. At 36 weeks, treatment with conc",
    "url": "https://finance.yahoo.com/news/eli-lilly-study-finds-zepbound-013134669.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "decdd05a-2eb3-3f12-8f69-a129cf31f570",
      "content": {
        "id": "decdd05a-2eb3-3f12-8f69-a129cf31f570",
        "contentType": "STORY",
        "title": "Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight",
        "description": "",
        "summary": "On Thursday, Eli Lilly and Co. (NYSE:LLY) revealed topline results from the novel TOGETHER-PsA open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone for active psoriatic arthritis (PsA) and obesity or overweight with at least one weight-related condition. Psoriatic arthritis is linked to psoriasis (a condition that affects skin and nails). It causes joint pain, stiffness, and a skin rash. At 36 weeks, treatment with conc",
        "pubDate": "2026-01-12T01:31:34Z",
        "displayTime": "2026-01-12T01:31:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Benzinga/ebc5670b38d99be85ea6a2f16ff0bb54",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0iWz1yDq.CSuFi.9R45_Dw--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/ebc5670b38d99be85ea6a2f16ff0bb54.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lSgReJnkqZecsqPPZ7zBjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/ebc5670b38d99be85ea6a2f16ff0bb54.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "http://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-study-finds-zepbound-013134669.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-study-finds-zepbound-013134669.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T08:10:20+00:00",
    "headline": "ðŸŽ§ Markets Last Week: Defense Stocks Rose, Beer Beat, Pharma Deal",
    "summary": "How did American oil companies respond to the U.S. action in Venezuela? Why were Constellation investors happy with lower beer sales? Plus, can a big pharmaceutical deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves last week and the news that drove them.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-12-2026/card/-markets-last-week-defense-stocks-rose-beer-beat-pharma-deal-70k35Bbxcihe7o36ppxS?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "73b15b5c-bbc4-3f07-899e-1e538d4e7eb5",
      "content": {
        "id": "73b15b5c-bbc4-3f07-899e-1e538d4e7eb5",
        "contentType": "STORY",
        "title": "ðŸŽ§ Markets Last Week: Defense Stocks Rose, Beer Beat, Pharma Deal",
        "description": "",
        "summary": "How did American oil companies respond to the U.S. action in Venezuela? Why were Constellation investors happy with lower beer sales? Plus, can a big pharmaceutical deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves last week and the news that drove them.",
        "pubDate": "2026-01-12T08:10:20Z",
        "displayTime": "2026-01-12T08:10:20Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/73b15b5c-bbc4-3f07-899e-1e538d4e7eb5/%F0%9F%8E%A7-markets-last-week-defense.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-12-2026/card/-markets-last-week-defense-stocks-rose-beer-beat-pharma-deal-70k35Bbxcihe7o36ppxS?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T10:03:00+00:00",
    "headline": "Abivax Surges on Report Ely Lily is Preparing $17.5 Billion Bid",
    "summary": "Shares in Abivax surged on a report that  Eli Lilly  was ready to offer 15 billion euros ($17.45 billion) for the biotech startup.  Stock in the French company rose 22% in early European trading to 120.80 euros after climbing as much as 30% earlier in the session.  It has a market capitalization of around 7.78 billion euros.",
    "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
      "content": {
        "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
        "contentType": "STORY",
        "title": "Abivax Surges on Report Ely Lily is Preparing $17.5 Billion Bid",
        "description": "",
        "summary": "Shares in Abivax surged on a report that  Eli Lilly  was ready to offer 15 billion euros ($17.45 billion) for the biotech startup.  Stock in the French company rose 22% in early European trading to 120.80 euros after climbing as much as 30% earlier in the session.  It has a market capitalization of around 7.78 billion euros.",
        "pubDate": "2026-01-12T10:03:00Z",
        "displayTime": "2026-01-12T10:03:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/fe057970-c6c6-386f-9920-c8e2f0dc2d38/abivax-surges-on-report-ely.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/70b7d4c1389db409b9e1fc36a775438a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sUf6G5CS045DS2VMIHzgWw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/70b7d4c1389db409b9e1fc36a775438a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z60wFKSaj18IKqHIUCGA_g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/70b7d4c1389db409b9e1fc36a775438a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T11:14:00+00:00",
    "headline": "Abivax shares surge after report flags continued Eli Lilly takeover interest",
    "summary": "Investing.com -- Shares in Abivax jumped sharply on Monday after a report said U.S. drugmaker Eli Lilly remains interested in acquiring the French biotech.",
    "url": "https://finance.yahoo.com/news/abivax-shares-surge-report-flags-111400639.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "dab409f1-460e-30af-9292-b8c81210803e",
      "content": {
        "id": "dab409f1-460e-30af-9292-b8c81210803e",
        "contentType": "STORY",
        "title": "Abivax shares surge after report flags continued Eli Lilly takeover interest",
        "description": "",
        "summary": "Investing.com -- Shares in Abivax jumped sharply on Monday after a report said U.S. drugmaker Eli Lilly remains interested in acquiring the French biotech.",
        "pubDate": "2026-01-12T11:14:00Z",
        "displayTime": "2026-01-12T11:14:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abivax-shares-surge-report-flags-111400639.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abivax-shares-surge-report-flags-111400639.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AAVXF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T10:03:00+00:00",
    "headline": "Abivax Surges on Report Ely Lilly is Preparing $17.5 Billion Bid",
    "summary": "Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.",
    "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
      "content": {
        "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
        "contentType": "STORY",
        "title": "Abivax Surges on Report Ely Lilly is Preparing $17.5 Billion Bid",
        "description": "",
        "summary": "Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.",
        "pubDate": "2026-01-12T10:03:00Z",
        "displayTime": "2026-01-12T10:03:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/fe057970-c6c6-386f-9920-c8e2f0dc2d38/abivax-surges-on-report-ely.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a0KQ6papa.xbdIRhdZYCpg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xfbO.4Knh6N3L0kymfSeuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:05:00+00:00",
    "headline": "Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors",
    "summary": "Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this investment, a total of $123 million in equity financing received from institutional and strategic investors to dateSeparately, Recludix announces collaboration with Lilly to utilize Lilly TuneLabâ„¢, a pioneering artificial intelligence and machine learning platform, to accelerate the development of Recludixâ€™s discovery pipeline SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Recludix",
    "url": "https://finance.yahoo.com/news/recludix-pharma-announces-equity-financing-130500214.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "23e1e315-0efb-36d7-8fb3-c9abdf159ab7",
      "content": {
        "id": "23e1e315-0efb-36d7-8fb3-c9abdf159ab7",
        "contentType": "STORY",
        "title": "Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors",
        "description": "",
        "summary": "Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this investment, a total of $123 million in equity financing received from institutional and strategic investors to dateSeparately, Recludix announces collaboration with Lilly to utilize Lilly TuneLabâ„¢, a pioneering artificial intelligence and machine learning platform, to accelerate the development of Recludixâ€™s discovery pipeline SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Recludix",
        "pubDate": "2026-01-12T13:05:00Z",
        "displayTime": "2026-01-12T13:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/3e3b7f225a2b77a1d1ea7d5025f01be2",
          "originalWidth": 842,
          "originalHeight": 325,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YBxgqYBDasfFycfbK8bENQ--~B/aD0zMjU7dz04NDI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3e3b7f225a2b77a1d1ea7d5025f01be2.cf.webp",
              "width": 842,
              "height": 325,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/knUi1j71UOIuwB0719OEbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3e3b7f225a2b77a1d1ea7d5025f01be2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recludix-pharma-announces-equity-financing-130500214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recludix-pharma-announces-equity-financing-130500214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:00:00+00:00",
    "headline": "Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors",
    "summary": "Commonwealth Fusion Systems (CFS), the largest and leading private fusion company, today announced that Stephane Bancel, the Chief Executive Officer of Moderna Inc. who led that company's successful development, production, scaling, and global adoption of the COVID-19 vaccine, has joined as an Independent Member of the Board of Directors.",
    "url": "https://finance.yahoo.com/news/commonwealth-fusion-systems-names-stephane-130000132.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "bded000d-3a58-3b3c-b11b-7046be448610",
      "content": {
        "id": "bded000d-3a58-3b3c-b11b-7046be448610",
        "contentType": "STORY",
        "title": "Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors",
        "description": "",
        "summary": "Commonwealth Fusion Systems (CFS), the largest and leading private fusion company, today announced that Stephane Bancel, the Chief Executive Officer of Moderna Inc. who led that company's successful development, production, scaling, and global adoption of the COVID-19 vaccine, has joined as an Independent Member of the Board of Directors.",
        "pubDate": "2026-01-12T13:00:00Z",
        "displayTime": "2026-01-12T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b97793f7da92c492e200f642baa5b1de",
          "originalWidth": 400,
          "originalHeight": 95,
          "caption": "Commonwealth Fusion Systems Logo (PRNewsfoto/Commonwealth Fusion Systems)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/owYIoMVoysNENfZHmnE60w--~B/aD05NTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/b97793f7da92c492e200f642baa5b1de.cf.webp",
              "width": 400,
              "height": 95,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6x9QQevw8RhDTEyNwha.bg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b97793f7da92c492e200f642baa5b1de.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/commonwealth-fusion-systems-names-stephane-130000132.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/commonwealth-fusion-systems-names-stephane-130000132.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "BMXMF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T10:03:00+00:00",
    "headline": "Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid",
    "summary": "Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.",
    "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
      "content": {
        "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
        "contentType": "STORY",
        "title": "Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid",
        "description": "",
        "summary": "Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.",
        "pubDate": "2026-01-12T10:03:00Z",
        "displayTime": "2026-01-12T10:03:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/fe057970-c6c6-386f-9920-c8e2f0dc2d38/abivax-surges-on-report-eli.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a0KQ6papa.xbdIRhdZYCpg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xfbO.4Knh6N3L0kymfSeuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:05:21+00:00",
    "headline": "Fed Chair Powell Faces US DOJ Criminal Probe, Equity Futures Waver Pre-Bell",
    "summary": "US equity futures were down ahead of Monday's opening bell after the US Department of Justice launch",
    "url": "https://finance.yahoo.com/news/fed-chair-powell-faces-us-140521462.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "c67cd4b7-4e89-3c3a-bbb4-420f9c3b4f29",
      "content": {
        "id": "c67cd4b7-4e89-3c3a-bbb4-420f9c3b4f29",
        "contentType": "STORY",
        "title": "Fed Chair Powell Faces US DOJ Criminal Probe, Equity Futures Waver Pre-Bell",
        "description": "",
        "summary": "US equity futures were down ahead of Monday's opening bell after the US Department of Justice launch",
        "pubDate": "2026-01-12T14:05:21Z",
        "displayTime": "2026-01-12T14:05:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fed-chair-powell-faces-us-140521462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fed-chair-powell-faces-us-140521462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:00:00+00:00",
    "headline": "CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program",
    "summary": "LOUISVILLE, Ky., January 12, 2026--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.",
    "url": "https://finance.yahoo.com/news/centerwell-pharmacy-dispense-obesity-management-140000778.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8191ee6c-7f90-37c6-ab86-37d4bc590bde",
      "content": {
        "id": "8191ee6c-7f90-37c6-ab86-37d4bc590bde",
        "contentType": "STORY",
        "title": "CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program",
        "description": "",
        "summary": "LOUISVILLE, Ky., January 12, 2026--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.",
        "pubDate": "2026-01-12T14:00:00Z",
        "displayTime": "2026-01-12T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a385ea1c73438a43509044f80083ad69",
          "originalWidth": 2334,
          "originalHeight": 952,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/avC7MLz9.maPskKvNkJP0w--~B/aD05NTI7dz0yMzM0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a385ea1c73438a43509044f80083ad69.cf.webp",
              "width": 2334,
              "height": 952,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u8AbGBmbEm_2u7g6j3Q8eQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a385ea1c73438a43509044f80083ad69.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/centerwell-pharmacy-dispense-obesity-management-140000778.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/centerwell-pharmacy-dispense-obesity-management-140000778.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "HUM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:45:00+00:00",
    "headline": "HealthDyne Helps Advance Access to Obesity Treatment by Supporting New Carve-Out Benefit Options",
    "summary": "HealthDyne announced it will participate in alternative access solutions for employers seeking access to FDA-approved obesity management medicine from Eli Lilly and Company (Lilly). HealthDyne will become a dispensing pharmacy for select Lilly medicines collaborating with digital healthcare providers to offer integrated carve-out solutions that combine affordability, clinical oversight and patient engagement.",
    "url": "https://finance.yahoo.com/news/healthdyne-helps-advance-access-obesity-134500839.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "0c8bc856-2338-33ba-8c50-e73d247d8d92",
      "content": {
        "id": "0c8bc856-2338-33ba-8c50-e73d247d8d92",
        "contentType": "STORY",
        "title": "HealthDyne Helps Advance Access to Obesity Treatment by Supporting New Carve-Out Benefit Options",
        "description": "",
        "summary": "HealthDyne announced it will participate in alternative access solutions for employers seeking access to FDA-approved obesity management medicine from Eli Lilly and Company (Lilly). HealthDyne will become a dispensing pharmacy for select Lilly medicines collaborating with digital healthcare providers to offer integrated carve-out solutions that combine affordability, clinical oversight and patient engagement.",
        "pubDate": "2026-01-12T13:45:00Z",
        "displayTime": "2026-01-12T13:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/ba72895b5fbeb779f550f8db39c2a7ba",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C7AiYx_nEJqBWJouorPP4g--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/ba72895b5fbeb779f550f8db39c2a7ba.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/riIBFlyAU7GxIafZY3HwgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ba72895b5fbeb779f550f8db39c2a7ba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/healthdyne-helps-advance-access-obesity-134500839.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/healthdyne-helps-advance-access-obesity-134500839.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T15:00:00+00:00",
    "headline": "NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery",
    "summary": "NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery. News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery.Chai Discovery, Basecamp Research, Boltz and ecosystem leaders connect NVIDIA BioNeM",
    "url": "https://finance.yahoo.com/news/nvidia-bionemo-platform-adopted-life-150000483.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "afd72fd4-a52d-34df-8d14-160c46a88f50",
      "content": {
        "id": "afd72fd4-a52d-34df-8d14-160c46a88f50",
        "contentType": "STORY",
        "title": "NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery",
        "description": "",
        "summary": "NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery. News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery.Chai Discovery, Basecamp Research, Boltz and ecosystem leaders connect NVIDIA BioNeM",
        "pubDate": "2026-01-12T15:00:00Z",
        "displayTime": "2026-01-12T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/231be7c6bbceb2b840a567565df830cf",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zbodgO5oxmH4Rv9PmUo.1Q--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/231be7c6bbceb2b840a567565df830cf.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_H_a.Z2heqxgOgcoztCbBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/231be7c6bbceb2b840a567565df830cf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-bionemo-platform-adopted-life-150000483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-bionemo-platform-adopted-life-150000483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T15:00:00+00:00",
    "headline": "NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI",
    "summary": "Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research NVIDIA and Lilly NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry. News Summary: NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery.The co-innovation l",
    "url": "https://finance.yahoo.com/news/nvidia-lilly-announce-co-innovation-150000104.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "b04464c1-3627-34b5-8ca4-6a1905b9090f",
      "content": {
        "id": "b04464c1-3627-34b5-8ca4-6a1905b9090f",
        "contentType": "STORY",
        "title": "NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI",
        "description": "",
        "summary": "Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research NVIDIA and Lilly NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry. News Summary: NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery.The co-innovation l",
        "pubDate": "2026-01-12T15:00:00Z",
        "displayTime": "2026-01-12T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/5e0080b8f9c1e3d09261ca3f4d7e5650",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TU4JlcNigdjT3_WaNC_Qnw--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/5e0080b8f9c1e3d09261ca3f4d7e5650.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WZ3OAq2pfw.zFwF0GnT.qg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5e0080b8f9c1e3d09261ca3f4d7e5650.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-lilly-announce-co-innovation-150000104.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-lilly-announce-co-innovation-150000104.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:51:00+00:00",
    "headline": "This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest.",
    "summary": "Eli Lillyâ€™s  presence in France has spanned more than six decades, but rumors of an acquisition suggest the pharmaceutical giant could be looking to expand its footprint in the country.  French outlet La Lettre reported Monday that biotechnology company  Abivax  had become the subject of takeover interest by Lilly, which was prepared to offer 15 billion euros, or roughly $17.5 billion, to acquire it.  Eli Lilly  has yet to support a formal bid to Abivaxâ€™s board as it awaits clarity from French regulators on whether a bid would be subject to Franceâ€™s foreign investment rules, the outlet reported.",
    "url": "https://www.barrons.com/articles/abivax-stock-price-eli-lilly-deal-d4360e1e?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "a7abd53d-3ed6-3631-bfad-37196920933b",
      "content": {
        "id": "a7abd53d-3ed6-3631-bfad-37196920933b",
        "contentType": "STORY",
        "title": "This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest.",
        "description": "",
        "summary": "Eli Lillyâ€™s  presence in France has spanned more than six decades, but rumors of an acquisition suggest the pharmaceutical giant could be looking to expand its footprint in the country.  French outlet La Lettre reported Monday that biotechnology company  Abivax  had become the subject of takeover interest by Lilly, which was prepared to offer 15 billion euros, or roughly $17.5 billion, to acquire it.  Eli Lilly  has yet to support a formal bid to Abivaxâ€™s board as it awaits clarity from French regulators on whether a bid would be subject to Franceâ€™s foreign investment rules, the outlet reported.",
        "pubDate": "2026-01-12T14:51:00Z",
        "displayTime": "2026-01-12T14:51:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a7abd53d-3ed6-3631-bfad-37196920933b/this-french-biotech-stock.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/aa4b51bd729b6cb38a349a611d8136aa",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dhNlx7ecuK6QafFFfsVpsw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/aa4b51bd729b6cb38a349a611d8136aa.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aUECCd97R2XwtfU7jy0ObQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/aa4b51bd729b6cb38a349a611d8136aa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/abivax-stock-price-eli-lilly-deal-d4360e1e?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AAVXF"
            },
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "FNLPF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:57:00+00:00",
    "headline": "RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models",
    "summary": "Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug discovery at scale.",
    "url": "https://finance.yahoo.com/news/rvty-eli-lilly-partner-expand-135700194.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "28d1979b-29b2-32f1-af12-38a0e9077220",
      "content": {
        "id": "28d1979b-29b2-32f1-af12-38a0e9077220",
        "contentType": "STORY",
        "title": "RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models",
        "description": "",
        "summary": "Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug discovery at scale.",
        "pubDate": "2026-01-12T13:57:00Z",
        "displayTime": "2026-01-12T13:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574",
          "originalWidth": 620,
          "originalHeight": 343,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N5xEJDQ9Yr4pXNEJ_c.8WA--~B/aD0zNDM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574.cf.webp",
              "width": 620,
              "height": 343,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j8jgIs0er2qzWmssl7aBuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rvty-eli-lilly-partner-expand-135700194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rvty-eli-lilly-partner-expand-135700194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            },
            {
              "symbol": "CRL"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T16:17:34+00:00",
    "headline": "JPM26: Eli Lilly reportedly eyes â‚¬15bn takeover of Abivax",
    "summary": "Abivaxâ€™s lead asset is obefazimod, an anti-inflammatory drug that has produced positive Phase III results.",
    "url": "https://www.pharmaceutical-technology.com/news/jpm26-eli-lilly-reportedly-eyes-e15bn-takeover-of-abivax/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "15ea28e6-b5de-3a26-895b-0e67fe1b2565",
      "content": {
        "id": "15ea28e6-b5de-3a26-895b-0e67fe1b2565",
        "contentType": "STORY",
        "title": "JPM26: Eli Lilly reportedly eyes â‚¬15bn takeover of Abivax",
        "description": "",
        "summary": "Abivaxâ€™s lead asset is obefazimod, an anti-inflammatory drug that has produced positive Phase III results.",
        "pubDate": "2026-01-12T16:17:34Z",
        "displayTime": "2026-01-12T16:17:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/4ec4aca828f81e62e94e7742026b1f18",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XAdWeoi2P6Dl_5Mp8rzNLg--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/4ec4aca828f81e62e94e7742026b1f18.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yP_alcZqHRAi6o7KKxJUoQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/4ec4aca828f81e62e94e7742026b1f18.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/jpm26-eli-lilly-reportedly-eyes-e15bn-takeover-of-abivax/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-eli-lilly-reportedly-eyes-161734787.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T16:00:00+00:00",
    "headline": "Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline",
    "summary": "REDWOOD CITY, Calif., January 12, 2026--Juvena Therapeutics, a clinical-stage biotechnology company whose AI-enabled regenerative biologics are designed to restore tissue function, today announced its $33.5 million Series B. The round was led by Bison Ventures with participation from Eli Lilly and Company, Jefferson Life Sciences, and existing institutional backers including Mubadala Capital and Manta Ray.",
    "url": "https://finance.yahoo.com/news/juvena-therapeutics-raises-33-5m-160000042.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "07e42e2e-0c72-30ad-9c12-f7ef274df8f0",
      "content": {
        "id": "07e42e2e-0c72-30ad-9c12-f7ef274df8f0",
        "contentType": "STORY",
        "title": "Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline",
        "description": "",
        "summary": "REDWOOD CITY, Calif., January 12, 2026--Juvena Therapeutics, a clinical-stage biotechnology company whose AI-enabled regenerative biologics are designed to restore tissue function, today announced its $33.5 million Series B. The round was led by Bison Ventures with participation from Eli Lilly and Company, Jefferson Life Sciences, and existing institutional backers including Mubadala Capital and Manta Ray.",
        "pubDate": "2026-01-12T16:00:00Z",
        "displayTime": "2026-01-12T16:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/6b1601d19f21ece17f11aaed7da924ad",
          "originalWidth": 480,
          "originalHeight": 284,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e9EpsPh_XHUyI_Oeva2ycg--~B/aD0yODQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6b1601d19f21ece17f11aaed7da924ad.cf.webp",
              "width": 480,
              "height": 284,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YGItkTCMIOmy.DpMsu33Vg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6b1601d19f21ece17f11aaed7da924ad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/juvena-therapeutics-raises-33-5m-160000042.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/juvena-therapeutics-raises-33-5m-160000042.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T15:27:43+00:00",
    "headline": "Nvidia Partners With Eli Lilly on AI Drug Laboratory",
    "summary": "Nvidia plans to invest $1 billion over five years in a new laboratory with&nbsp;Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.&nbsp;Jessica Nix has more on \"Bloomberg Open Interest.\"",
    "url": "https://finance.yahoo.com/video/nvidia-partners-eli-lilly-ai-152743875.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "03e99bf2-f48c-3c42-8bea-4e8ff4f9db1e",
      "content": {
        "id": "03e99bf2-f48c-3c42-8bea-4e8ff4f9db1e",
        "contentType": "VIDEO",
        "title": "Nvidia Partners With Eli Lilly on AI Drug Laboratory",
        "description": "Nvidia plans to invest $1 billion over five years in a new laboratory withÂ Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.Â Jessica Nix has more on \"Bloomberg Open Interest.\"",
        "summary": "Nvidia plans to invest $1 billion over five years in a new laboratory with&nbsp;Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.&nbsp;Jessica Nix has more on \"Bloomberg Open Interest.\"",
        "pubDate": "2026-01-12T15:27:43Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_markets_video_2/2418f3bccb232dd3cd0d3d9ccd1a2539",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AmdAIghX5MZA_AEh9xVGjA--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_video_2/2418f3bccb232dd3cd0d3d9ccd1a2539.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wy0RIX3HA.sZYZwBN9CrRg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_markets_video_2/2418f3bccb232dd3cd0d3d9ccd1a2539.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/nvidia-partners-eli-lilly-ai-152743875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/nvidia-partners-eli-lilly-ai-152743875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:45:04+00:00",
    "headline": "Here's Why Eli Lilly (LLY) is a Strong Growth Stock",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finance.yahoo.com/news/heres-why-eli-lilly-lly-144504168.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "52d67e4d-575b-38d4-b2d6-99c01f258a6d",
      "content": {
        "id": "52d67e4d-575b-38d4-b2d6-99c01f258a6d",
        "contentType": "STORY",
        "title": "Here's Why Eli Lilly (LLY) is a Strong Growth Stock",
        "description": "",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "pubDate": "2026-01-12T14:45:04Z",
        "displayTime": "2026-01-12T14:45:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VQTahvfxY5Qw8Ld_ibk8SA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uIfVIw8I.vo0_xUfE1XIrw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-eli-lilly-lly-144504168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-eli-lilly-lly-144504168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]